Eva Doleželová
Impact in
- Obstetrics and Gynecology top 10%
- Pregnancy and preeclampsia studies
-
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 9
-
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Stanislav Mičuda (17 shared papers)Petr Nachtigal (14 shared papers)M Hroch (11 shared papers)Jolana Cermanová (11 shared papers)František Štaud (3 shared papers)Carmelo Bernabéu (5 shared papers)Lukáš Červený (2 shared papers)Martina Čečková (2 shared papers)
- Journals
- Atherosclerosis (3 papers)Physiological Research (2 papers)Life Sciences (2 papers)Scientific Reports (1 paper)The FASEB Journal (1 paper)
- Partner nations
- CzechiaSpainUnited States
In The Last Decade
Eva Doleželová
24 papers receiving 488 citations
Peers
Comparison fields: 5 of 73
- Obstetrics and Gynecology 58
- Oncology 129
- Pharmacology 41
- Biochemistry 32
- Cardiology and Cardiovascular Medicine 70
Countries citing papers authored by Eva Doleželová
This map shows the geographic impact of Eva Doleželová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Doleželová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Doleželová more than expected).
Fields of papers citing papers by Eva Doleželová
This network shows the impact of papers produced by Eva Doleželová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Doleželová. The network helps show where Eva Doleželová may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Doleželová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 55 | |
| 2 | 2012 | 48 | |
| 3 | 2017 | 35 | |
| 4 | 2012 | 34 | |
| 5 | 2018 | 31 | |
| 6 | 2012 | 26 | |
| 7 | 2015 | 26 | |
| 8 | 2012 | 24 | |
| 9 | 2019 | 22 | |
| 10 | 2016 | 21 | |
| 11 | 2017 | 21 | |
| 12 | 2014 | 21 | |
| 13 | 2015 | 19 | |
| 14 | 2019 | 17 | |
| 15 | 2017 | 17 | |
| 16 | 2017 | 15 | |
| 17 | 2016 | 13 | |
| 18 | 2020 | 12 | |
| 19 | 2019 | 10 | |
| 20 | 2014 | 9 |
About Eva Doleželová
Eva Doleželová is a scholar working on Oncology, Epidemiology, Pharmacology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 25 papers that have together received 492 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Cholesterol and Lipid Metabolism (3 papers), Trace Elements in Health (3 papers), Hormonal Regulation and Hypertension (3 papers), Iron Metabolism and Disorders (3 papers) and Pregnancy and Medication Impact (2 papers). The work is most often cited by research in Obstetrics and Gynecology (58 citations), Oncology (129 citations), Pharmacology (41 citations), Biochemistry (32 citations) and Cardiology and Cardiovascular Medicine (70 citations). Eva Doleželová has collaborated with scholars based in Czechia, Spain and United States. Frequent co-authors include Stanislav Mičuda, Petr Nachtigal, M Hroch, Jolana Cermanová, František Štaud, Carmelo Bernabéu, Lukáš Červený, Martina Čečková, Ivana Němečková and Jana Rathouska. Their work appears in journals such as Atherosclerosis, Physiological Research, Life Sciences, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.